Short answer
To register SaMD in Malaysia you classify it (Class A to D under the Medical Device Regulations 2012), appoint a Malaysian Authorised Representative that is licensed by MDA and GDPMD-certified, and apply through MeDC@St. Class B, C and D devices need a CAB registered with MDA. If your software already holds an EU MDR Notified Body certificate, the CAB uses the verification route (MDA/GD/0070) instead of a full assessment: about 1.5 months at the CAB, then 30 working days for MDA’s decision. MDA’s own fees for Class B are RM 250 + RM 1,000, and registration is valid for five years.
Malaysia's regulatory framework for medical devices
Malaysia's Medical Device Authority (MDA), part of the Ministry of Health Malaysia, operates under the Medical Device Act 2012 (Act 737) and the Medical Device Regulations 2012. It is responsible for registering medical devices, licensing establishments and post-market vigilance for all medical devices placed on the Malaysian market — including software as a medical device (SaMD).
Like the ASEAN Medical Device Directive, Malaysia uses four risk classes (A to D). For devices that already hold an approval from a recognised authority — including an EU Notified Body certificate under the MDR — MDA offers conformity assessment by way of verification: a Conformity Assessment Body (CAB) verifies the existing evidence instead of repeating a full conformity assessment.
Registration applications are submitted through MDA's online system, MeDC@St. The guidance documents most relevant to EU-certified SaMD companies are MDA/GD/0070 (registration through conformity assessment by way of verification, second edition, October 2025), MDA/GD/0068 (the CAB guide for verification), MDA/GD/0009 (classification rules for general medical devices) and MDA/GD/0026 (labelling).
SaMD classification under Malaysia MDA: Class A, B, C, D
All medical devices — including software — must be classified before registration, using the classification rules of the Medical Device Regulations 2012 (explained for general medical devices in MDA/GD/0009). The class determines whether a CAB is involved and which fees apply.
| Class | Risk level | SaMD examples (depend on intended purpose) | CAB required? | Registration route |
|---|---|---|---|---|
| Class A | Low | Low-risk software with a medical purpose. Software without a medical purpose (general wellness, purely administrative tools) is not a medical device at all | No — exempt under the Medical Device (Exemption) Order 2024 | Application directly to MDA in MeDC@St |
| Class B | Low–moderate | Often clinical decision support or monitoring software for non-critical conditions | Yes | CAB conformity assessment (full or verification) + MDA registration |
| Class C | Moderate–high | Often software that drives diagnosis or treatment decisions for serious conditions | Yes | CAB conformity assessment (full or verification) + MDA registration |
| Class D | High | Highest-risk devices; less common for standalone software | Yes | CAB conformity assessment (full or verification) + MDA registration |
In practice, software that provides clinical recommendations, assists in diagnosis or influences treatment decisions is rarely Class A; whether it is Class B or C depends on the intended purpose and the seriousness of the condition addressed.
Malaysia applies its own classification rules, not EU MDR Rule 11. Outcomes are often similar, but they can differ — particularly for AI/ML software and software with indirect diagnostic functions — so document the Malaysian classification rationale rather than copying your EU class. The verification route also requires the device to have the same design and intended purpose as the approved device.
Two conformity assessment routes: full and verification
For Class B, C and D devices the CAB step takes one of two forms. Which one applies depends on whether the device already holds a recognised approval — not on whether it is registered in Singapore.
| Factor | Full conformity assessment | Verification (recognised approval) |
|---|---|---|
| When it applies | No qualifying approval, or the approval has been cancelled or invalidated | Approval from at least one recognised authority — EU Notified Body certificate (MDR, IVDR or listed Directives), US FDA, Health Canada, TGA, Japan MHLW, UK MHRA, Singapore HSA (SMDR) or Thai FDA |
| Conditions | — | Same design and intended purpose; no associated safety issues worldwide in the last year; no rejection or withdrawal by a recognised authority |
| CAB work | Full conformity assessment | Verification of the manufacturer's evidence: QMS, post-market data, technical documentation, Declaration of Conformity |
| CAB turnaround | HSA cites 60 working days for MDA's full route | Approx. 1.5 months (MDA/GD/0070); HSA cites 30 working days |
| MDA decision | See MDA guidance for the full route | 30 working days after complete documents and cleared payment (Class B–D) |
| Best for | Devices without a recognised approval | EU MDR certified SaMD |
Full conformity assessment
If your device has no recognised approval — or the approval has been cancelled or invalidated — the CAB performs a full conformity assessment before you apply to MDA. For an EU MDR certified SaMD whose certificate covers the same device and intended purpose, this route is normally not needed.
Conformity assessment by way of verification
Under MDA/GD/0070, Class B, C and D devices with a recognised approval go through verification: the CAB verifies the evidence, issues a report and a certificate of conformity valid for five years, and your Authorised Representative submits the registration in MeDC@St. MDA's guidance gives an approximate CAB turnaround of 1.5 months and 30 working days for MDA's decision on a complete application; you have up to 90 working days to answer MDA's requests for information.
MDA now also recognises Singapore SMDR listings and Thai FDA approvals for this route, and moved its programmes with HSA and Thai FDA to full implementation on 1 March 2026 and 1 May 2026 respectively. For an EU MDR certified SaMD this adds flexibility rather than a shortcut — see our Singapore + Malaysia reliance guide.
Choosing a Conformity Assessment Body (CAB)
Class B, C and D registrations need a CAB registered with MDA under section 10 of Act 737 — MDA's FAQ states that CAB recognition must come from a local CAB registered under that section — and MDA/GD/0070 asks you to appoint a CAB with expertise in the relevant medical device technical areas. Check MDA's current list of registered CABs and their scope before engaging one; we do not reproduce or rank CABs here because registrations and scopes change.
When selecting a CAB, ask specifically about its experience with SaMD submissions and with IEC 62304 and ISO 14971 documentation. A reviewer who mainly handles physical devices may ask for information that does not fit software, which costs time. Ask for references from previous software clients before committing.
Malaysian Authorised Representative: requirements and selection
A manufacturer not based in Malaysia must authorise an Authorised Representative (AR) to act on its behalf (MDA/GD/0070). The AR must be licensed and domiciled in Malaysia, and only manufacturers and ARs apply for medical device registration.
What your Malaysian AR must hold
- MDA establishment licence: ARs, importers and distributors all need an establishment licence. Check that its scope matches your intended distribution arrangement
- GDPMD certificate (Good Distribution Practice for Medical Devices): MDA sets GDPMD as the quality-system requirement for the supply chain — the AR, importers and distributors. It is certified by a CAB and submitted with the establishment licence application. Build GDPMD currency checks into your AR qualification process
- MeDC@St access: applications are submitted in MeDC@St by the establishment — a local manufacturer or your AR; a foreign manufacturer does not submit directly
AR responsibilities and what to verify
The AR applies for the registration and, together with you, carries the post-market obligations in Malaysia: mandatory problem reports (MDA/GD/0014) and field corrective action notifications (MDA/GD/0013) are made by the manufacturer or its AR. An AR cannot be the brand owner. Its compliance failures can become your market access problems. Before appointing an AR:
- Obtain its establishment licence and check the licence number, scope and expiry
- Obtain its GDPMD certificate and check scope and expiry — do not rely on self-declaration
- Confirm its experience with SaMD specifically (not just physical devices)
- Clarify who holds the MeDC@St account and who manages communication with MDA
- Review its process for vigilance reporting if you also have EU MDR and UK obligations
Step-by-step registration process for Class B SaMD
The following sequence assumes the verification route on the basis of your EU MDR certificate. The full conformity assessment route follows the same steps, with a full assessment at step 5.
- Confirm classification: apply the Malaysian classification rules to your intended purpose. If borderline B/C, prepare conservative documentation and document your rationale
- Appoint Authorised Representative: engage and formally authorise a licensed Malaysian AR. Agree responsibilities, termination and data access in writing, and obtain copies of its establishment licence and GDPMD certificate
- Prepare the dossier: compile the CSDT-based dossier listed in MDA/GD/0070 Annex 4 — executive summary, essential principles checklist, device description, design verification and validation summary (including software verification and validation), clinical evaluation report, labelling, risk analysis to ISO 14971:2019 and manufacturer information — plus the QMS certificate, evidence of the recognised approval, a summary of reportable adverse events and field corrective actions over the past three years, and the Declaration of Conformity
- Select and engage CAB: appoint an MDA-registered CAB with expertise in the relevant technical areas and submit the dossier for verification
- CAB verification: approximately 1.5 months under MDA's guidance, excluding the time you take to respond. Answer CAB questions promptly and completely
- CAB report and certificate of conformity: issued after a positive decision; the certificate is valid for five years
- MDA registration submission: your AR submits in MeDC@St — the same technical dossier the CAB reviewed, in English and/or Bahasa Malaysia — with the CAB report and certificate, the Declaration of Conformity and the fees
- MDA registration: MDA decides within 30 working days of complete documents and cleared payment. Registration is valid for five years; the re-registration function opens one year before expiry
Documentation requirements for Class B SaMD
The dossier for registration through verification must include the following elements (MDA/GD/0070, Annex 4). Missing or incomplete sections are a common cause of questions and delays.
Administrative section
- The AR's establishment licence (with GDPMD certification) — current copies
- Evidence that the manufacturer has authorised the AR to act on its behalf
- MeDC@St application and fee payment
Technical documentation (CSDT)
- Executive summary and essential principles checklist
- Device description and intended purpose — matching your EU MDR intended purpose
- Design verification and validation summary, including software verification and validation (your IEC 62304 evidence)
- Risk analysis to ISO 14971:2019
- Updated clinical evaluation report
- Labelling and manufacturer information
Conformity assessment evidence
- Evidence of the recognised approval — your EU MDR Notified Body certificate, within its validity period
- ISO 13485 certificate, or an accepted equivalent (MDSAP, US FDA QSR, Japan MHLW Ordinance 169)
- Summary of reportable adverse events and field corrective actions for the past three years
- Declaration of Conformity according to Appendix 3 of the Third Schedule to the Medical Device Regulations 2012 (see MDA/GD/0025), on company letterhead and signed by top management
- CAB report and certificate of conformity
Labelling
- Your EU labels and IFU are the starting point, adapted to MDA/GD/0026 (7th edition, May 2026)
- Name, address and at least one contact detail of the Malaysian AR
- Language: English for devices other than home-use devices; Bahasa Malaysia for home-use devices
- The Malaysian registration number on labelling within six months of registration
- Electronic IFU is possible for professional-use devices, based on a documented risk analysis
The full requirements, including e-IFU rules for software, are in our Malaysia medical device labelling guide.
Registration fees and costs
MDA's own fees are set out in MDA/GD/0070, per application, for a five-year registration:
| Class | Application fee (RM) | Registration fee (RM) |
|---|---|---|
| Class A | 100 | — |
| Class B | 250 | 1,000 |
| Class C | 500 | 2,000 |
| Class D | 700 | 3,000 |
CAB fees, Authorised Representative fees and consultancy costs are not set by MDA. They vary with the provider, the device and the scope of post-market support, so ask for written quotes; we do not publish ranges for them. Well-maintained EU MDR documentation that adapts cleanly to the CSDT keeps rework — and therefore cost — down.
GDPMD: what it is and why it matters for your market access
GDPMD (Good Distribution Practice for Medical Devices) is easy to overlook when you focus on the technical dossier, but it is operationally critical. MDA sets GDPMD as the quality-system requirement for those in the medical device supply chain — the Authorised Representative, importers and distributors. The certificate is assessed and issued by a CAB and submitted with the establishment licence application; manufacturers need ISO 13485 instead.
Because only manufacturers and ARs can apply for registration, and you depend on your AR for submissions and post-market reporting, a lapse in your AR's licensing or certification puts your Malaysian market access at risk — even if your own compliance is in order.
What GDPMD covers for SaMD
GDPMD addresses distribution and supply-chain activities. For software, that means in practice how the software is delivered and updated, how complaints and adverse events are handled and escalated, and how supply to end users is traced. Ask your AR how its GDPMD procedures cover software rather than physical products. What to check in the AR’s licence and GDPMD certificate, and what the licences cost, is covered in our GDPMD guide.
How to keep track of GDPMD status
- Request the AR's establishment licence and GDPMD certificate and check the company name, scope and expiry dates
- Confirm that the GDPMD scope covers your device type and the activities in your distribution arrangement
- Diarise expiry dates and ask for renewed certificates in good time
- Keep copies with your AR onboarding records
- Repeat the check annually, and whenever your AR reports an MDA inspection or compliance event
Post-market obligations in Malaysia
Malaysian registration is valid for five years, but post-market obligations apply from the moment your device is on the Malaysian market (see also: EU MDR PMS obligations that run in parallel).
Adverse event reporting
Under MDA/GD/0014 (Mandatory Problem Reporting), the manufacturer or its AR reports incidents to MDA within 48 hours of becoming aware that an incident is a serious threat to public health, within 10 days for incidents that led, or could lead, to death or serious deterioration in health, and within 30 days for other reportable incidents. An investigation report follows within 30 days of the initial report.
Your QMS needs a Malaysia-specific procedure. If you also have EU MDR obligations, a single event may require reports to EU competent authorities, the MHRA (for the UK), MDA and HSA. Build a multi-market vigilance workflow — this is a common gap in companies expanding from EU-only to Asian markets.
Field Safety Corrective Actions
Under MDA/GD/0013, the manufacturer or its AR must notify MDA before initiating a field corrective action, and submit an FCA report within 30 days after its completion. For imported devices, inform your AR as soon as you decide on an FCA. Your QMS must specify how multi-market FSCAs are triggered and coordinated.
Changes after registration
Changes to a registered device are currently notified under MDA/GD/0020 (Category 1, 2 or 3). MDA has published its replacement, MDA/GD/0072, which takes effect when MeDC@St 3.0 launches and adds a dedicated software flowchart and a predetermined change control plan for SaMD; see our Malaysia change management guide.
Certificate renewal
Registration is valid for five years. The re-registration function in MeDC@St becomes available one year before expiry, and re-registration can again use the verification route if the registration is still valid and there are no unnotified changes to the design, specifications or registration information. Track expiry dates from the day you receive registration.
- ↗Malaysia MDA — official portal — Malaysia MDA
- ↗MDA/GD/0070 (2nd ed., Oct 2025) — registration through conformity assessment by way of verification — Malaysia MDA
- ↗MDA/GD/0068 — CAB guide for conformity assessment by way of verification — Malaysia MDA
- ↗HSA approvals accepted via the Verification Route — full implementation from 1 March 2026 — Malaysia MDA
- ↗FAQ — registration, licensing and enforcement (AR, establishment licence, GDPMD) — Malaysia MDA
- ↗MDA/GD/0026 (7th ed., May 2026) — labelling requirements — Malaysia MDA
- ↗MDA/GD/0014 — mandatory problem reporting — Malaysia MDA
- ↗MDA/GD/0013 — field corrective action — Malaysia MDA